Danish pharmaceutical giant Novo Nordisk is gearing up to introduce its blockbuster anti-diabetes and weight-loss drug Wegovy (semaglutide) in India. In a strategic move to gain an advantage over Eli Lilly’s newly launched Mounjaro (tirzepatide), Novo Nordisk has presented data showcasing Wegovy’s cardiovascular benefits in Indian patients, according to recent regulatory filings.
Dense Fog Disrupts Operations at Delhi Airport, over 140 Flights Cancelled and 150 Delayed
Operations at Delhi’s Indira Gandhi International Airport (IGIA) were severely affected on Wednesday due to dense fog and extremely low visibility. Airport officials reported that at least 148 flights were cancelled and...





Discussion about this post